22:23 , Sep 21, 2018 |  BioCentury  |  Finance

Flying Delta in Japan

That Delta-Fly Pharma Inc. is slated to become only the third biotech to go public on Tokyo Stock Exchange’s Mothers in three years is the latest reminder that tough listing standards are still making it...
00:43 , Mar 25, 2017 |  BioCentury  |  Finance

Solasia goes to market

After becoming the first Japanese biotech to go public in 18 months, Solasia Pharma K.K. (Tokyo:4597) plans to use the proceeds to prepare to launch its first products in China. Solasia raised ¥3.6 billion ($32...
15:31 , Mar 24, 2017 |  BC Extra  |  Financial News

Solasia rises after pricing Japanese IPO

Solasia Pharma K.K. (Tokyo:4597) gained ¥87 (47%) to ¥272 in its first day of trading Friday on Tokyo Stock Exchange's Mothers. The company raised ¥3.6 billion ($32 million) through the sale of 19.4 million shares...
07:00 , May 2, 2016 |  BioCentury  |  Finance

Rational retail in Japan

The 2012 Japanese biotech bubble was fueled by irrational retail exuberance over a Nobel Prize awarded to a stem cell academic, but retail investors now are largely rewarding companies based on news events or upcoming...
08:00 , Jan 4, 2016 |  BioCentury  |  Finance

Curbed enthusiasm

Following three years of investor exuberance manifested in gains of at least 115% in biotech indices, buysiders say a good 2016 would see biotech merely keeping pace with the broader markets. Nobody is calling an...
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

GreenPeptide completes IPO

GreenPeptide Co. Ltd. , Fukuoka, Japan   Business: Cancer   Date completed: 2015-10-13   Type: IPO   Raised: Y2.9 billion ($24.3 million)   Shares: 6.5 million   Price: Y450   Shares after offering: 31.8 million...
07:00 , Oct 5, 2015 |  BioCentury  |  Finance

Volatile, not futile

Bankers and buysiders are not ready to call the end of the biotech bull on the heels of the sector's worst quarter in more than 13 years. But they do expect volatility to persist through...
07:00 , Sep 21, 2015 |  BC Week In Review  |  Financial News

GreenPeptide proposes IPO

GreenPeptide Co. Ltd. , Fukuoka, Japan   Business: Cancer   Date announced: 2015-09-14   Type: IPO   To be raised: TBD   Shares: 6.5 million   Price: TBD   Underwriters: Mizuho; Ichiyoshi; Ace Securities; SBI...